# Heron Therapeutics (HRTX) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/HRTX
## Company Profile
- Ticker: HRTX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 0.3238 USD
- Market cap: 85175716.05 USD
- Last updated: 2026-08-11
## Business Overview
### Acute-Care Medicines
Heron Therapeutics commercializes medicines used in surgical pain management and oncology supportive care. Its portfolio is designed for administration in hospitals, ambulatory surgery centers and infusion settings.
### ZYNRELEF
ZYNRELEF is an extended-release local anesthetic combining bupivacaine and meloxicam for postoperative pain. Heron is developing a ready-to-use prefilled syringe intended to improve preparation and operating-room efficiency.
### Oncology Supportive Care
CINVANTI and APONVIE are injectable antiemetic products used to prevent nausea and vomiting associated with chemotherapy or surgery. These products complement the company's acute-care commercial infrastructure.
## Why The Stock Is Moving

Following the latest company update, “Heron Therapeutics Announces Second Quarter 2026 Financial Results”, HRTX closed down 31.7% at $0.3350 on Aug 10, 2026. The move occurred in the trading session associated with this earnings update.

## Recent News
- 2026-08-10 12:00 EST — [Heron Therapeutics Announces Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/HRTX/heron-therapeutics-announces-second-quarter-2026-financial-results-808f9c16) — Source: Heron Therapeutics
- 2026-07-27 12:30 EST — [Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026](https://biopharmsignal.com/news/HRTX/heron-therapeutics-to-report-second-quarter-2026-financial-results-on-monday-aug-c850c6e7) — Source: Heron Therapeutics
- 2026-06-02 12:12 EST — [U.S. District Court Issues Decision Regarding CINVANTI® Patents](https://biopharmsignal.com/news/HRTX/u-s-district-court-issues-decision-regarding-cinvanti-patents-21c1ecf3) — Source: Heron Therapeutics
- 2026-05-11 12:00 EST — [Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance](https://biopharmsignal.com/news/HRTX/heron-therapeutics-announces-first-quarter-2026-financial-results-and-reaffirms--bde6d661) — Source: Heron Therapeutics
- 2026-04-27 21:30 EST — [Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026](https://biopharmsignal.com/news/HRTX/heron-therapeutics-to-report-first-quarter-2026-financial-results-on-monday-may--8ba7e861) — Source: Heron Therapeutics